Decitabine priming prior to low-dose chemotherapy improves patient outcomes in myelodysplastic syndromes-RAEB: a retrospective analysis vs. chemotherapy alone

PURPOSE: The aim of this study was to examine whether decitabine priming prior to low-dose chemotherapeutic regimens could improve outcomes in patients with myelodysplastic syndromes—refractory anemia with excess of blasts (MDS-RAEB). METHODS: The current retrospective analysis included all MDS-RAEB...

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Li, Ren, Yanling, Zhou, Xinping, Mei, Chen, Ma, Liya, Ye, Xingnong, Wei, Juying, Xu, Weilai, Meng, Haitao, Qian, Wenbin, Mai, Wenyuan, Lou, Yinjun, Xu, Gaixiang, Qian, Jiejing, Lou, Yejiang, Luo, Yingwan, Xie, Lili, Lin, Peipei, Hu, Chao, Jin, Jie, Tong, Hongyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Original Article – Clinical Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5384967/
https://www.ncbi.nlm.nih.gov/pubmed/28108816
http://dx.doi.org/10.1007/s00432-016-2331-0

Ejemplares similares

Ejemplares similares